Lead Product(s) : IMP761
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Immutep
Deal Size : Undisclosed
Deal Type : Agreement
Immutep Advances IMP761 Manufacturing
Details : Under the agreement, Northway has already started developing a GMP-compliant manufacturing process of IMP761 and will manufacture IMP761 in large scale bioreactors. Planning for further pre-clinical and clinical development is ongoing.
Product Name : IMP761
Product Type : Antibody
Upfront Cash : Undisclosed
December 16, 2021
Lead Product(s) : IMP761
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Immutep
Deal Size : Undisclosed
Deal Type : Agreement